-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-270-bimp-disposition-comments.pdf
September 18, 2024 - One commenter was concerned about our components approach to analyze data for Key
Question 1. … The hardest problem in our review was to determine how to analyze studies that
used many of the same … One approach, taken
by the related Sharpe Cochrane review, would have been to analyze all behavioral … The other extreme would be to analyze each treatment combination on its own (e.g.,
first a section on
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-meta-analysis.ppt
June 01, 2012 - Deciding Which Metrics To Meta-analyze (1 of 6)
Trikalinos TA, Coleman CI, Griffith L, et al. … Why does it make sense to directly meta-analyze sensitivity and specificity? … Deciding Which Metrics To Meta-analyze (3 of 6)
Trikalinos TA, Coleman CI, Griffith L, et al. … Rarely is it meaningful to meta-analyze each value across studies. … Deciding Which Metrics To Meta-analyze (4 of 6)
It is less helpful to meta-analyze predictive values
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-meta-analysis.ppt
June 01, 2012 - Deciding Which Metrics To Meta-analyze (1 of 6)
Trikalinos TA, Coleman CI, Griffith L, et al. … Why does it make sense to directly meta-analyze sensitivity and specificity? … Deciding Which Metrics To Meta-analyze (3 of 6)
Trikalinos TA, Coleman CI, Griffith L, et al. … Rarely is it meaningful to meta-analyze each value across studies. … Deciding Which Metrics To Meta-analyze (4 of 6)
It is less helpful to meta-analyze predictive values
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/models-care-adult-survivors-childhood-cancer-evidence-summary.pdf
February 01, 2022 - researchers) and conducted
targeted and iterative searching to (1) identify models of survivorship care and analyze … identify available tools, training, and other resources for childhood cancer
survivorship care and analyze
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/search-strategy-white-paper.pdf
February 01, 2025 - Below are the narrative sections of the review form:
• What to analyze: Entire record | Title Field … | Abstract Field | Subject Field
• Methods to analyze: Boolean/Truncation support? … These steps lend themselves to tools that
analyze structured bibliographic records using word frequency … evaluation (Table 5) and deduplication (Table 8) steps also include a
number of useful tools that analyze … COMMENTS: While this tool does analyze the results of a search and provide counts of words
and phrases
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced%20-appendix-2.xlsx
May 29, 2025 - CED proposal should include the end date for coverage by CED with time to analyze evidence gathered and … most recently made to the CED program in 2014, allowing for almost a decade of real-world examples to analyze … most recently made to the CED program in 2014, allowing for almost a decade of real-world examples to analyze … duration set for accrual of data CED proposal should include the end date for coverage by CED with time to analyze
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
September 01, 2007 - They determine that information technology tools that
analyze administrative data recorded using ICD9 … Fisher et al., (1987) conducted a study to analyze the effectiveness of post-marketing
surveillance … surveillance
admin
Initiate
surveillance
Collect
baseline and
follow-up data
Contact FDA-
ODS
Analyze … We analyze each of these factors and identify the critical elements of the community
pharmacy based … We then analyze the critical success factors for the DERMS-based post marketing
surveillance mechanism
-
effectivehealthcare.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
September 01, 2007 - They determine that information technology tools that
analyze administrative data recorded using ICD9 … Fisher et al., (1987) conducted a study to analyze the effectiveness of post-marketing
surveillance … surveillance
admin
Initiate
surveillance
Collect
baseline and
follow-up data
Contact FDA-
ODS
Analyze … We analyze each of these factors and identify the critical elements of the community
pharmacy based … We then analyze the critical success factors for the DERMS-based post marketing
surveillance mechanism
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-241-wheelchair-users-disposition-comments.pdf
October 18, 2022 - Most studies that met inclusion
criteria did not report HR or RPE
making it difficult to analyze results … Most studies that met inclusion
criteria did not report HR or RPE
making it difficult to analyze results
-
effectivehealthcare.ahrq.gov/sites/default/files/ahrq_community_forum_webinar_bonoff.pdf
January 01, 2000 - methodology course to prepare advocates to serve on breast cancer
decision-making bodies and to critically analyze
-
effectivehealthcare.ahrq.gov/sites/default/files/bonoff-text.pdf
January 01, 2000 - methodology course to
prepare advocates to serve on breast cancer decision-making bodies and to critically
analyze
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
May 29, 2025 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Evidence-Tables-E1-E4_0.xlsx
May 29, 2025 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
May 29, 2025 - NPP
Table E-1. Neuropathic pain study characteristics
Author, Year
Country
Trial Type
Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized
N Analyzed Intervention Duration (Weeks) Funding Source
Hussain, 2021
Pakistan
Placebo-controlled
Fair NPP (DPN) Age, mean: 45
Female: 0%
R…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
January 01, 2022 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
January 01, 2022 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % P…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
January 01, 2023 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
January 01, 2023 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
January 01, 2022 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
January 01, 2022 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…